Novel antiviral agents for respiratory viral infection in immunocompromised adults.

about

Poor positive predictive value of influenza-like illness criteria in adult transplant patients: a case for multiplex respiratory virus PCR testing.

P2860

Q40140647-E9201C9C-A0B3-4E82-92C5-168BB117A854

P2860

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

Item

http://www.wikidata.org/entity/Q42243405

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@en

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@nl

type

Item

label

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@en

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@nl

prefLabel

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@en

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@nl

P1476

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

@en

P2093

Dana Hawkinson

http://www.w3.org/2001/XMLSchema#string

Daniel Hinthorn

http://www.w3.org/2001/XMLSchema#string

Lara Danziger-Isakov

http://www.w3.org/2001/XMLSchema#string

P2860

Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients

Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09

DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.

Influenza, including the novel H1N1, in organ transplant patients.

Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.

P304

497-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11908-013-0370-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24146257

http://www.w3.org/2001/XMLSchema#string

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

about

P2860

P2860

Novel antiviral agents for respiratory viral infection in immunocompromised adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698